{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:15Z","timestamp":1787032815550,"version":"build-2736575974"},"reference-count":27,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012319","name":"Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec id=\"abs1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The degree of heterotypic immunity induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains is a major determinant of the spread of emerging variants and the success of vaccination campaigns, but remains incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We examined the immunogenicity of SARS-CoV-2 variant B.1.1.7 (Alpha) that arose in the United Kingdom and spread globally. We determined titres of spike glycoprotein-binding antibodies and authentic virus neutralising antibodies induced by B.1.1.7 infection to infer homotypic and heterotypic immunity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Antibodies elicited by B.1.1.7 infection exhibited significantly reduced recognition and neutralisation of parental strains or of the South Africa variant B.1.351 (Beta) than of the infecting variant. The drop in cross-reactivity was significantly more pronounced following B.1.1.7 than parental strain infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The results indicate that heterotypic immunity induced by SARS-CoV-2 variants is asymmetric.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs5\">\n                    <jats:title>Funding:<\/jats:title>\n                    <jats:p>This work was supported by the Francis Crick Institute and the Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7554\/elife.69317","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T08:00:36Z","timestamp":1627545636000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.69317","source":"Crossref","is-referenced-by-count":37,"title":["Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains"],"prefix":"10.7554","volume":"10","author":[{"given":"Nikhil","family":"Faulkner","sequence":"first","affiliation":[{"name":"Retroviral Immunology, London, United Kingdom"},{"name":"National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1635-6768","authenticated-orcid":true,"given":"Kevin W","family":"Ng","sequence":"additional","affiliation":[{"name":"Retroviral Immunology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2074-6171","authenticated-orcid":true,"given":"Mary Y","family":"Wu","sequence":"additional","affiliation":[{"name":"High Throughput Screening STP, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Harvey","sequence":"additional","affiliation":[{"name":"Worldwide Influenza Centre, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Margaritis","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Paraskevopoulou","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Houlihan","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"},{"name":"Division of Infection and Immunity, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Hussain","sequence":"additional","affiliation":[{"name":"Worldwide Influenza Centre, London, United Kingdom"},{"name":"RNA Virus Replication Laboratory, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Greco","sequence":"additional","affiliation":[{"name":"RNA Virus Replication Laboratory, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bolland","sequence":"additional","affiliation":[{"name":"Retroviral Immunology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Warchal","sequence":"additional","affiliation":[{"name":"High Throughput Screening STP, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Heaney","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Rickman","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moria","family":"Spyer","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"},{"name":"Department of Population, Policy and Practice, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Frampton","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Byott","sequence":"additional","affiliation":[{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulio","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa"},{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa"},{"name":"Centre for the AIDS Programme of Research in South Africa, Durban, South Africa"},{"name":"Department of Global Health, University of Washington, Seattle, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-2004","authenticated-orcid":true,"given":"Alex","family":"Sigal","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa"},{"name":"Africa Health Research Institute, Durban, South Africa"},{"name":"Max Planck Institute for Infection Biology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-8683","authenticated-orcid":true,"given":"Svend","family":"Kjaer","sequence":"additional","affiliation":[{"name":"Structural Biology STP, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[{"name":"Cancer Evolution and Genome Instability Laboratory, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Neurodegradation Biology Laboratory, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-8560","authenticated-orcid":true,"given":"Rupert","family":"Beale","sequence":"additional","affiliation":[{"name":"Cell Biology of Infection Laboratory, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve J","family":"Gamblin","sequence":"additional","affiliation":[{"name":"Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-6347","authenticated-orcid":true,"given":"John W","family":"McCauley","sequence":"additional","affiliation":[{"name":"Worldwide Influenza Centre, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney Stuart","family":"Daniels","sequence":"additional","affiliation":[{"name":"Worldwide Influenza Centre, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Howell","sequence":"additional","affiliation":[{"name":"High Throughput Screening STP, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bauer","sequence":"additional","affiliation":[{"name":"RNA Virus Replication Laboratory, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Nastouli","sequence":"additional","affiliation":[{"name":"Retroviral Immunology, London, United Kingdom"},{"name":"Advanced Pathogen Diagnostics Unit UCLH NHS Trust, London, United Kingdom"},{"name":"Department of Population, Policy and Practice, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-2633","authenticated-orcid":true,"given":"George","family":"Kassiotis","sequence":"additional","affiliation":[{"name":"Retroviral Immunology, London, United Kingdom"},{"name":"Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41587-020-0588-y","article-title":"Scalable and robust SARS-CoV-2 testing in an academic center","volume":"38","author":"Aitken","year":"2020","journal-title":"Nature Biotechnology"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.24.432576","article-title":"Increased transmission of Sars-Cov-2 lineage b.1.1.7 (Voc 2020212\/01) Is not accounted for by a replicative advantage in primary airway cells or antibody escape","volume-title":"bioRxiv","author":"Brown","year":"2021"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","article-title":"Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma","volume":"593","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-228079\/v","article-title":"Sars-Cov-2 variants show resistance to neutralization by many monoclonal and Serum-Derived polyclonal antibodies","volume":"5","author":"Diamond","year":"2021","journal-title":"Research Square"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.20.432046","article-title":"Reduced binding and neutralization of infection- and Vaccine-Induced antibodies to the b.1.351 (South african) Sars-Cov-2 variant","volume-title":"bioRxiv","author":"Edara","year":"2021"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: gisaid's innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Global Challenges"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0140-6736(21)00628-0","article-title":"Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012\/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial","volume":"397","author":"Emary","year":"2021","journal-title":"The Lancet"},{"key":"bib8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00170-5","article-title":"Genomic characteristics and clinical effect of the emergent SARS-CoV-2 b.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study","volume":"12","author":"Frampton","year":"2021","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.06.028316","article-title":"Extraction-Free Covid-19 (Sars-Cov-2) Diagnosis by Rt-Pcr to increase capacity for national testing programmes during a pandemic","volume-title":"bioRxiv","author":"Grant","year":"2020"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/S0140-6736(20)31484-7","article-title":"Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers","volume":"396","author":"Houlihan","year":"2020","journal-title":"The Lancet"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.8.30466","article-title":"Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017","volume":"22","author":"ICONIC Consortium","year":"2017","journal-title":"Eurosurveillance"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Molecular Biology and Evolution"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2213-2600(21)00005-9","article-title":"New variant of SARS-CoV-2 in UK causes surge of COVID-19","volume":"9","author":"Kirby","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2021.06.020","article-title":"Reduced neutralization of Sars-Cov-2 b.1.617 by vaccine and convalescent serum","volume":"187","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1056\/NEJMc2102017","article-title":"Neutralizing activity of BNT162b2-Elicited serum","volume":"384","author":"Liu","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nature Medicine"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.06.434193","article-title":"Sars-Cov-2 501y.V2 (B.1.351) Elicits Cross-Reactive neutralizing antibodies","volume-title":"bioRxiv","author":"Moyo-Gwete","year":"2021"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"Ng","year":"2020","journal-title":"Science"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Molecular Biology and Evolution"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 b.1.1.7 and b.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nature Medicine"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-226857\/v1","article-title":"Vaccine-Induced immunity provides more robust heterotypic immunity than natural infection to emerging Sars-Cov-2 variants of concern","volume":"2021","author":"Skelly","year":"2021","journal-title":"Research Square"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(21)01462-8","article-title":"AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC","volume":"398","author":"Wall","year":"2021","journal-title":"The Lancet"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(21)01290-3","article-title":"Neutralising antibody activity against SARS-CoV-2 VOCs b.1.617.2 and b.1.351 by BNT162b2 vaccination","volume":"397","author":"Wall","year":"2021","journal-title":"The Lancet"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.25.428137","article-title":"Antibody resistance of Sars-Cov-2 variants b.1.351 and b.1.1.7","volume-title":"bioRxiv","author":"Wang","year":"2021"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.18.427166","article-title":"Sars-Cov-2 501y.V2 escapes neutralization by south african Covid-19 donor plasma","volume-title":"bioRxiv","author":"Wibmer","year":"2021"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant b.1.351 from natural and vaccine-induced sera","volume":"184","author":"Zhou","year":"2021","journal-title":"Cell"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/69317\/elife-69317-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/69317\/elife-69317-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/69317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:18:27Z","timestamp":1697059107000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/69317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":27,"alternative-id":["10.7554\/eLife.69317"],"URL":"https:\/\/doi.org\/10.7554\/elife.69317","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.01.433314","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2021.03.01.433314","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.69317.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.69317.sa1","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e69317"}}